Guest Blog:  by Jennifer Douglas,  Founder Homegrown4Heroes In recent months, the cannabis community supporting veterans through Homegrown4Heroes (HG4H) has faced an unprecedented challenge. Hurricane Helene, a powerful and destructive storm, ravaged vast portions of the East Coast, leaving behind a path of devastation, not only in homes and infrastructure but also in the green fields where HG4H’s growers cultivate their crops. The hurricane struck at a critical point in the cultivation season, wiping out an estimated 70% of HG4H’s projected harvest. The consequences ..read more

ASA's Monthly Newsletter! Back by popular demand, we are proud to bring you the ASA Monthly Newsletter! We can only continue to do this important work with your support, consider becoming an ASA member today! ASA has recently revamped our Member Benefits Program, adding new benefits for our members each month like the 20% off offer on Nectar Products (see article below on Nectar) & 50% off registration for the upcoming Validated Voices Summit in September. Is your membership Current? Learn More about ASA Member Benefits & Join Today! What's Inside For September 2024: DEA Hearing ..read more

Join Americans for Safe Access (ASA) for a Roundtable discussion on cannabis product recalls with key stakeholders to discuss the basics of recalls, how they work, what they mean for patients and consumer health, and why they signal a functioning cannabis regulatory system ..read more

Americans for Safe Access (ASA) fully supports the regulation of cannabinoid products as part of our mission to ensure safe access for patients, and we want you to be successful in your efforts to do so in California.  We have consistently called for federal oversight of these products and supported the spirit of AB 2223 but requested a minor yet crucial amendment to address a major issue affecting some of California’s most vulnerable residents.  Unfortunately, our efforts to alter the legislation to protect these patients failed, and so did AB 2223.  Please Don’t Make Patient I ..read more

For Immediate Release: September 5, 2024 AMID RECENT CANNABIS RECALLS, AMERICANS FOR SAFE ACCESS RELEASES CRITICAL REPORT:  "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety" Washington, D.C.– Following a concerning series of cannabis recalls due to contamination, Americans for Safe Access (ASA) announced the release of a crucial new resource today: "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety." This comprehensive guide aims to empower patients and consumers with the knowledge needed to safeguard their health i ..read more

For Immediate Release: August 28, 2024  Washington, D.C. — In light of the Drug Enforcement Administration’s (DEA) announcement to schedule a hearing on the rescheduling of cannabis, Americans for Safe Access (ASA) emphasizes the urgent need for compassionate leadership in Congress to advocate for the rights of medical cannabis patients. The DEA’s decision to postpone federal reform until after November leaves millions of patients and their families in uncertainty ..read more

For immediate release: Media Briefing on the Next Steps of the Rescheduling Process July 22, 2024, 1 pm ET Zoom Conference: Please go to the bottom of this page for the Zoom sign-in link. Healthcare Experts & Cannabis Stakeholders Clear the Smoke on Cannabis Scheduling: Join a Physician, Pharmacist, Researcher, Caregiver, Veteran, Patients, and Patient Advocates as They Bring the Rescheduling Debate to Life Washington, DC – Public comment closes today on the Department of Justice’s (DOJ) proposed rule to move cannabis (marijuana) from Schedule I to Schedule III. This transition shifts ..read more

Cannabis has Currently Accepted Medical Use in Treatment in The United States! Medical cannabis advocates have been waiting to hear these words from Health and Human Services (HHS) and the Department of Justice (DOJ) for 50 years! The Biden Administration's rescheduling recommendation to remove cannabis from Schedule I to Schedule III are based on these magic words. The experiences of medical professionals and research produced from state medical cannabis programs made this qualification possible.  Despite the lack of focus on medical cannabis patients in recent news coverage on reschedu ..read more

CONTACT: Steph Sherer, steph@safeaccessnow.org, (510) 872-7822   Media Advisory: References for Reporting on HHS Report and Cannabis Rescheduling and Statement from ASA   ASA’s Statement on HHS “I am excited to see that the Food & Drug Administration (FDA) incorporated many of Americans for Safe Access’ suggestions in their approach to the scheduling process and ASA’s data was utilized, resulting in their conclusion that cannabis does in fact have accepted medical use” said Steph Sherer, Founder & President of Americans for Safe Access. "We are hopeful that the DEA will agre ..read more

By Joseph Billions for Cannabis.Net Maine medical marijuana tests out at 50% contaminated in a spot check! Do you remember the Cannabis.net story on how Colorado regulators are catching all sorts of cheating on lab testing for legally sold cannabis?  The premise destroys the idea that you should be paying more for lab-tested, legal weed, because, well, it was safer than street sold marijuana.  Now, not only are Colorado regulators catching legal suppliers spraying and cheating on lab results, Maine has popped up as a big problem for legal buyer of medical marijuana ..read more